PAVmed Valuation

PAVM Stock  USD 0.77  0.01  1.32%   
PAVmed is undervalued. PAVmed Inc holds a recent Real Value of $2.79 per share. The prevailing price of the entity is $0.77. Our model determines the value of PAVmed Inc from inspecting the entity fundamentals such as Return On Asset of -0.96, shares outstanding of 13.64 M, and Profit Margin of 6.03 % as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting PAVmed's valuation include:
Price Book
7.4172
Enterprise Value
47.8 M
Enterprise Value Ebitda
4.0561
Price Sales
2.5825
Enterprise Value Revenue
11.8527
Undervalued
Today
0.77
Please note that PAVmed's price fluctuation is very risky at this time. Calculation of the real value of PAVmed Inc is based on 3 months time horizon. Increasing PAVmed's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the PAVmed stock is determined by what a typical buyer is willing to pay for full or partial control of PAVmed Inc. Since PAVmed is currently traded on the exchange, buyers and sellers on that exchange determine the market value of PAVmed Stock. However, PAVmed's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.77 Real  2.79 Target  9.0 Hype  0.75 Naive  0.74
The intrinsic value of PAVmed's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence PAVmed's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
2.79
Real Value
8.43
Upside
Estimating the potential upside or downside of PAVmed Inc helps investors to forecast how PAVmed stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of PAVmed more accurately as focusing exclusively on PAVmed's fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
-0.67-0.67-0.67
Details
Hype
Prediction
LowEstimatedHigh
0.040.756.39
Details
Naive
Forecast
LowNext ValueHigh
0.010.746.38
Details
3 Analysts
Consensus
LowTarget PriceHigh
8.199.009.99
Details
Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use PAVmed's intrinsic value based on its ongoing forecasts of PAVmed's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against PAVmed's closest peers.

PAVmed Cash

18.93 Million

PAVmed Valuation Trend

Knowing PAVmed's actual value is paramount for traders when making sound investment determinations. Using both PAVmed's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.

PAVmed Total Value Analysis

PAVmed Inc is at this time anticipated to have valuation of 47.81 M with market capitalization of 10.42 M, debt of 48.73 M, and cash on hands of 68.47 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the PAVmed fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
47.81 M
10.42 M
48.73 M
68.47 M

PAVmed Investor Information

About 29.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 1.14. PAVmed Inc had not issued any dividends in recent years. The entity had 1:15 split on the 7th of December 2023. Based on the measurements of operating efficiency obtained from PAVmed's historical financial statements, PAVmed Inc may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.

PAVmed Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. PAVmed has an asset utilization ratio of 7.4 percent. This suggests that the Company is making $0.074 for each dollar of assets. An increasing asset utilization means that PAVmed Inc is more efficient with each dollar of assets it utilizes for everyday operations.
 
Yuan Drop
 
Covid

PAVmed Ownership Allocation

The market capitalization of PAVmed Inc is $10.42 Million. PAVmed Inc has noticeable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Note, that even with negative profits, if the true value of the entity is larger than the current market value, you may still be able to generate positive returns on investment in this company.

PAVmed Profitability Analysis

The company reported the previous year's revenue of 2.45 M. Net Loss for the year was (64.17 M) with loss before overhead, payroll, taxes, and interest of (2.37 M).

About PAVmed Valuation

We use absolute and relative valuation methodologies to arrive at the intrinsic value of PAVmed Inc. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of PAVmed Inc based exclusively on its fundamental and basic technical indicators. By analyzing PAVmed's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of PAVmed's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of PAVmed. We calculate exposure to PAVmed's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of PAVmed's related companies.
Last ReportedProjected for Next Year
Gross Profit-3.6 M-3.4 M
Pretax Profit Margin(29.09)(30.55)
Operating Profit Margin(25.25)(26.51)
Net Loss(23.56)(24.73)
Gross Profit Margin(1.86)(1.95)

PAVmed Growth Indicators

Investing in growth stocks can be very risky. If the company such as PAVmed does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding7.2 M

PAVmed Current Valuation Indicators

PAVmed's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final PAVmed's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as PAVmed, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use PAVmed's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes PAVmed's worth.
When determining whether PAVmed Inc is a strong investment it is important to analyze PAVmed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact PAVmed's future performance. For an informed investment choice regarding PAVmed Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PAVmed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PAVmed. If investors know PAVmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PAVmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.14)
Revenue Per Share
0.45
Quarterly Revenue Growth
0.259
Return On Assets
(0.96)
Return On Equity
(13.58)
The market value of PAVmed Inc is measured differently than its book value, which is the value of PAVmed that is recorded on the company's balance sheet. Investors also form their own opinion of PAVmed's value that differs from its market value or its book value, called intrinsic value, which is PAVmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PAVmed's market value can be influenced by many factors that don't directly affect PAVmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PAVmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if PAVmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PAVmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.